![Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker]()
Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor BlockerFURUMATSU, Yoshiyuki; NAGASAWA, Yasuyuki; TOMIDA, Kodo; MIKAMI, Satoshi; KANEKO, Tetsuya; OKADA, Noriyuki; TSUBAKIHARA, Yoshiharu; IMAI, Enyu; SHOJI, Tatsuya · Hypertension Research · 2008